Latest Insider Transactions at Tarsus Pharmaceuticals, Inc. (TARS)
This section provides a real-time view of insider transactions for Tarsus Pharmaceuticals, Inc. (TARS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tarsus Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tarsus Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-33.33%
|
-
|
|
Nov 09
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.77%
|
$153,000
$17.87 P/Share
|
|
Oct 20
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.23%
|
$80,000
$16.26 P/Share
|
|
Oct 19
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.34%
|
$136,000
$17.26 P/Share
|
|
Oct 12
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.38%
|
$144,000
$16.0 P/Share
|
|
Sep 21
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.34%
|
$128,000
$16.67 P/Share
|
|
Sep 15
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.78%
|
$80,000
$16.03 P/Share
|
|
Sep 14
2022
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
18,400
+50.0%
|
$294,400
$16.16 P/Share
|
|
Sep 14
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.75%
|
$144,000
$16.01 P/Share
|
|
Aug 24
2022
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,188
+4.34%
|
$25,940
$5.72 P/Share
|
|
Aug 18
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.22%
|
$80,000
$16.3 P/Share
|
|
Aug 17
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.33%
|
$128,000
$16.97 P/Share
|
|
Aug 15
2022
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
3,749
+31.65%
|
-
|
|
Aug 15
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-25.0%
|
-
|
|
Jun 15
2022
|
Michael Ackermann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,257
+0.35%
|
-
|
|
May 05
2022
|
Michael Ackermann Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$1,300,000
$13.5 P/Share
|
|
May 05
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,374
-0.22%
|
$64,488
$12.25 P/Share
|
|
May 04
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,738
-0.79%
|
$236,856
$12.67 P/Share
|
|
May 03
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
451,418
-15.33%
|
$5,868,434
$13.25 P/Share
|
|
May 02
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
41,800
-1.4%
|
$627,000
$15.19 P/Share
|
|
Dec 01
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,833
-0.12%
|
$145,825
$25.31 P/Share
|
|
Dec 01
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.12%
|
$145,825
$25.26 P/Share
|
|
Nov 11
2021
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
4,348
+50.0%
|
-
|
|
Nov 11
2021
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
250,000
-22.48%
|
-
|
|
Nov 08
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,889
-3.63%
|
$52,892
$28.11 P/Share
|
|
Nov 05
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11
-0.02%
|
$308
$28.11 P/Share
|
|
Nov 04
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.19%
|
$2,800
$28.03 P/Share
|
|
Nov 02
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-5.2%
|
$156,000
$26.91 P/Share
|
|
Nov 01
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,833
-0.24%
|
$157,491
$27.99 P/Share
|
|
Nov 01
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.24%
|
$157,491
$27.97 P/Share
|
|
Oct 12
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,531
-0.23%
|
$138,275
$25.97 P/Share
|
|
Oct 12
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,633
-0.23%
|
$146,458
$26.01 P/Share
|
|
Oct 08
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
302
-0.02%
|
$7,550
$25.02 P/Share
|
|
Oct 08
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$5,000
$25.03 P/Share
|
|
Sep 10
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,593
-4.27%
|
$57,046
$22.15 P/Share
|
|
Sep 10
2021
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,943
+5.52%
|
$34,715
$5.72 P/Share
|
|
Sep 01
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,833
-0.24%
|
$145,825
$25.82 P/Share
|
|
Sep 01
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.48%
|
$145,825
$25.24 P/Share
|
|
Aug 11
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
621
-0.05%
|
$15,525
$25.15 P/Share
|
|
Aug 11
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
1,917
-0.16%
|
$47,925
$25.07 P/Share
|
|
Aug 10
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
103
-0.01%
|
$2,575
$25.0 P/Share
|
|
Aug 09
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
827
-0.03%
|
$20,675
$25.07 P/Share
|
|
Aug 09
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
700
-0.06%
|
$17,500
$25.0 P/Share
|
|
Aug 06
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
1,616
-0.13%
|
$40,400
$25.0 P/Share
|
|
Aug 06
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
3,129
-0.25%
|
$78,225
$25.0 P/Share
|
|
Aug 05
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
1,370
-0.11%
|
$34,250
$25.0 P/Share
|
|
Aug 05
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
1,383
-0.04%
|
$34,575
$25.0 P/Share
|
|
Jun 25
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,704
-0.26%
|
$223,416
$29.6 P/Share
|
|
Jun 24
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.33%
|
$290,000
$29.9 P/Share
|
|
Jun 23
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,980
-1.25%
|
$1,101,420
$29.8 P/Share
|